Chronic Myeloid Leukemia: Modern therapies, current challenges and future directions

AEG Osman, MW Deininger - Blood reviews, 2021 - Elsevier
Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm caused by a reciprocal
translocation [t (9; 22)(q34; q11. 2)] that leads to the fusion of ABL1 gene sequences (9q34) …
被引用次数：118 相关文章

Chronic Myeloid Leukemia: Modern therapies, current challenges and future directions

AEG Osman, MW Deininger - Blood reviews, 2021 - pubmed.ncbi.nlm.nih.gov
Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm caused by a reciprocal
translocation [t (9; 22)(q34; q11. 2)] that leads to the fusion of ABL1 gene sequences (9q34) …

Chronic Myeloid Leukemia: Modern therapies, current challenges and future directions.

AEG Osman, MW Deininger - Blood Reviews, 2021 - europepmc.org
Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm caused by a reciprocal
translocation [t (9; 22)(q34; q11. 2)] that leads to the fusion of ABL1 gene sequences (9q34) …
[HTML] nih.gov

[HTML][HTML] Chronic Myeloid Leukemia: Modern therapies, current challenges and future directions

AEG Osman, MW Deininger - Blood reviews, 2021 - ncbi.nlm.nih.gov
Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm caused by a reciprocal
translocation [t (9; 22)(q34; q11. 2)] that leads to the fusion of ABL1 gene sequences (9q34) …

Chronic Myeloid Leukemia: Modern therapies, current challenges and future directions

AEG Osman, MW Deininger - Blood Reviews, 2021 - Elsevier
Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm caused by a reciprocal
translocation [t (9; 22)(q34; q11. 2)] that leads to the fusion of ABL1 gene sequences (9q34) …